This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Biomarkers: Top Demanding Technology In Healthcare, 2018

Author: Abhinav Chandra
by Abhinav Chandra
Posted: Jan 12, 2018

Biomarkers are molecules that indicate normal or abnormal process taking place in your body and may be a sign of an underlying condition or disease. Various types of molecules, such as DNA (genes), proteins or hormones, can serve as biomarkers since they all indicate something about your health.

Global Biomarker Market for Diagnostic Applications is expected to garner $30.6 Billion Globally by 2020, registering a CAGR of 16% during the forecast period 2013 to 2020.

Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. However, application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020.

Digital biomarkers:

Digital biomarkers are defined as the objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, and implantable. Consumer-facing digital tools have led to the birth of so-called digital biomarkers, which show promise in helping consumers and doctors gain insight into health and disease. Digital Biomarkers enable new value chains on health data.

Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic add the analysts.

With respect to geography, Asia Pacific is expected to have the highest CAGR at 20.3% from 2013 to 2020. Companies profiled in this report include Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), G.E. Healthcare Inc. (U.K)

Diagnostic biomarkers though are a great tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are related to a genomic pattern of an individual which needs to be extremely confidential.

Some other biomarkers are Lung cancer biomarkers, Protein biomarkers, Pacific Biomarkers.

For More Information and Source, Click here

About the Author

Senior Research Analyst at Allied Research. Master of Business Administration (Mba) focused on Business Statistics Management, General from Symbiosis Schools of Management, India.

Leave a Comment
Author Thumbnail
Please or Join to add a comment.
Author: Abhinav Chandra

Abhinav Chandra

Flag of India

Member since: Dec 19, 2017
Total live articles: 2

Related Articles